Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
1,818 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01725633 | Aerobic Training in Metastatic Breast Cancer(Breast Mets) | completed | N/A | 27 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Apr 6, 2023 | clinicaltrials |
| NCT00587067 | A Phase II Study of Continuous Hepatic Arterial Infusion With Floxuridine (FUDR) and Dexamethasone (DEX) in Patients With Unresectable Primary Hepatic Malignancy | completed | Phase 2 | 34 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Apr 4, 2023 |
| clinicaltrials |
| NCT00611598 | DNA Repair and Genetic Susceptibility to Lung Cancer | completed | — | 218 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Mar 29, 2023 | clinicaltrials |
| NCT01393509 | The First-in-human Phase I Trial of PU-H71 in Patients With Advanced Malignancies | completed | Phase 1 | 47 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Mar 28, 2023 | clinicaltrials |
| NCT04635735 | Study of Ipilimumab After Stem Cell Transplantation in People With Relapsed/Refractory Multiple Myeloma | terminated | Phase 1 / Phase 2 | 3 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Mar 23, 2023 | clinicaltrials |
| NCT02954536 | Phase II Trial of Pembrolizumab With Trastuzumab and Chemotherapy in Advanced HER2 Positive Esophagogastric (EG) Cancer | completed | Phase 2 | 37 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Mar 16, 2023 | clinicaltrials |
| NCT02549989 | Study of LY3023414 for the Treatment of Recurrent or Persistent Endometrial Cancer | completed | Phase 2 | 28 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Feb 22, 2023 | clinicaltrials |
| NCT04868045 | Study of Resistance to Thyroid Hormone After Long-term Exposure in People With Thyroid Cancer | withdrawn | Phase 1 | 0 | Memorial Sloan Kettering Cancer CenterOTHER | 0 | Feb 21, 2023 | clinicaltrials |
| NCT00579579 | Functional Outcomes and Quality of Life in Patients Undergoing Surgery for Rectal Cancer | completed | — | 229 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Feb 17, 2023 | clinicaltrials |
| NCT02217891 | IFACT: Incidental Findings in Advanced Cancer Therapy(IFACT) | completed | — | 60 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Feb 13, 2023 | clinicaltrials |
| NCT01356251 | Psychosocial Needs and Exploration of Online Support for Patients With Mesothelioma | completed | N/A | 107 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Feb 8, 2023 | clinicaltrials |
| NCT02281383 | Evaluate the Response to 2 Induction Courses (12 Intravesical Instillations) of Bacillus Calmette-Guérin (BCG) for High Risk Superficial Bladder Cancer | completed | Phase 2 | 80 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Feb 8, 2023 | clinicaltrials |
| NCT01379287 | Dose-Escalation Safety and Pharmacokinetic Study of Iso-Fludelone in Patients With Advanced Solid Tumors | completed | Phase 1 | 29 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Feb 2, 2023 | clinicaltrials |
| NCT04510285 | A Single-Arm Pilot Study of Adjuvant Pembrolizumab Plus Trastuzumab in HER2+ Esophagogastric Tumors With Persistent Circulating Tumor DNA Following Curative Resection | terminated | Phase 2 | 1 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Feb 1, 2023 | clinicaltrials |
| NCT01649661 | MRI Parenchymal Enhancement: A New Marker of Breast Cancer Risk | completed | — | 437 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jan 26, 2023 | clinicaltrials |
| NCT02120807 | Certolizumab in Combination With Chemotherapy for Patients With Stage IV Lung Adenocarcinomas | completed | Phase 1 | 30 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jan 26, 2023 | clinicaltrials |
| NCT01423734 | The Reproducibility Of Diffusion Weighted Magnetic Resonance Imaging For Neuroendocrine Tumor Liver Metastases | completed | — | 20 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jan 23, 2023 | clinicaltrials |
| NCT02941900 | Interest and Impact of Skin Cancer Genetic Testing | completed | — | 53 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jan 20, 2023 | clinicaltrials |
| NCT02833883 | Use of an Experimental Drug, CC-115, With Enzalutamide in Men With Castration-Resistant Prostate Cancer | completed | Phase 1 | 40 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jan 19, 2023 | clinicaltrials |
| NCT01456104 | Immune Responses to Autologous Langerhans-type Dendritic Cells Electroporated With mRNA Encoding a Tumor-associated Antigen in Patients With Malignancy: A Single-arm Phase I Trial in Melanoma | completed | Phase 1 | 9 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jan 13, 2023 | clinicaltrials |
| NCT02308241 | Ribavirin for Patients With Recurrent/Metastatic (R/M) Human Papillomavirus (HPV)-Related Malignancies | completed | N/A | 12 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jan 5, 2023 | clinicaltrials |
| NCT03843593 | A Study To See Why Patients Agree To or Decline To Have Treatment After Surgery | completed | — | 38 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jan 4, 2023 | clinicaltrials |
| NCT01596257 | Bulk Versus Fractionated Stem Cell Infusions in Patients With Hematologic Malignancies Undergoing Stem Cell Transplantation | completed | Phase 2 | 116 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Dec 29, 2022 | clinicaltrials |
| NCT01642186 | Study of (1) Everolimus, (2) Estrogen Deprivation Therapy (EDT) With Leuprolide + Letrozole and (3) Everolimus + EDT in Patients With Unresectable Fibrolamellar Hepatocellular Carcinoma (FLL-HCC) | completed | Phase 2 | 28 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Dec 29, 2022 | clinicaltrials |
| NCT01882816 | Intensity-Modulated Radiation Therapy (IMRT) in the Treatment of Non-Anaplastic Non-Medullary Thyroid Cancer | completed | Phase 2 | 27 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Dec 29, 2022 | clinicaltrials |
| NCT01974804 | Assessment of Early Treatment Response by Diffusion and Perfusion MRI in Patients With Brain Metastasis | completed | — | 30 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Dec 29, 2022 | clinicaltrials |
| NCT02849171 | Assessing 11C-Choline (11C-CH) PET to Distinguish True Tumor Progression From Pseudoprogression in High-grade Gliomas | completed | N/A | 8 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Dec 29, 2022 | clinicaltrials |
| NCT00423514 | Clofarabine, Melphalan, and Thiotepa Followed By a Donor Stem Cell Transplant in Treating Patients With High-Risk and/or Advanced Hematologic Cancer or Other Disease | completed | Phase 1 / Phase 2 | 38 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Dec 27, 2022 | clinicaltrials |
| NCT00582842 | Longitudinal Assessment of Health-Related Quality of Life in Men With Localized Prostate Cancer | completed | — | 1,800 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Dec 27, 2022 | clinicaltrials |
| NCT03520504 | Study of Proton Radiation to the Brain and Spinal Cord for Patients With Leptomeningeal Metastases | completed | Phase 1 | 24 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Dec 23, 2022 | clinicaltrials |
| NCT02037945 | 18F-Fluorocholine (18F-FCho) to Distinguish Necrosis From Recurrence in Brain Metastases | completed | N/A | 19 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Dec 19, 2022 | clinicaltrials |
| NCT03877055 | A Study of Copanlisib and Ibrutinib in Mantle Cell Lymphoma | completed | Phase 1 / Phase 2 | 8 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Dec 14, 2022 | clinicaltrials |
| NCT00739141 | Conditioning Regimen and the Transplantation of Unrelated Donor Umbilical Cord Blood in Patients With Hematologic Malignancies. | completed | Phase 2 | 86 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Dec 8, 2022 | clinicaltrials |
| NCT00805129 | Everolimus (RAD001) in Metastatic Transitional Cell Carcinoma of the Urothelium | completed | Phase 2 | 46 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Nov 25, 2022 | clinicaltrials |
| NCT03344536 | A Study of Debio 1347 Plus Fulvestrant in Patients With Metastatic Breast Cancer | completed | Phase 1 / Phase 2 | 10 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Nov 25, 2022 | clinicaltrials |
| NCT02924324 | Local Injection of Pain Medication to Reduce Pain After Bone Marrow Procedures in Pediatric Neuroblastoma Patients | completed | N/A | 56 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Nov 8, 2022 | clinicaltrials |
| NCT02730130 | Study to Assess the Efficacy of Pembrolizumab Plus Radiotherapy in Metastatic Triple Negative Breast Cancer Patients | completed | Phase 2 | 17 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Oct 19, 2022 | clinicaltrials |
| NCT02756247 | A Clinical Trial of Buparlisib and Ibrutinib in Lymphoma | completed | Phase 1 | 37 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Oct 10, 2022 | clinicaltrials |
| NCT02910726 | A Study Comparing Green Fluorescent Dye and Radioactive Dye for Sentinel Lymph Node Biopsy in Pediatric Cancers | completed | Phase 2 / Phase 3 | 6 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Oct 5, 2022 | clinicaltrials |
| NCT03082677 | Study of Ixazomib to Prevent Recurrent or Late Acute and Chronic Graft-versus-Host Disease 1-year After Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Hematologic Malignancies | completed | Phase 2 | 20 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Sep 27, 2022 | clinicaltrials |
| NCT00588211 | Measurement of Cancer-Related Risk Perception in Smokers | completed | — | 1,514 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Sep 16, 2022 | clinicaltrials |
| NCT03769753 | Trial of IRE in Cholangiocarcinoma | completed | Phase 2 | 8 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Sep 10, 2022 | clinicaltrials |
| NCT01621906 | 18F-FLT-PET Imaging of the Brain in Patients With Metastatic Breast Cancer to the Brain Treated With Whole Brain Radiation Therapy With or Without Sorafenib: Comparison With MR Imaging of the Brain | completed | N/A | 17 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Sep 9, 2022 | clinicaltrials |
| NCT03342586 | Using a Novel Functional MRI Technique to Evaluate for Neurotoxicity | completed | — | 14 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Aug 8, 2022 | clinicaltrials |
| NCT01119066 | HLA-Compatible Related or Unrelated Donors With CD34+ Enriched, T-cell Depleted Peripheral Blood Stem Cells Isolated by the CliniMACS System in the Treatment of Patients With Hematologic Malignancies | completed | Phase 2 | 422 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Aug 5, 2022 | clinicaltrials |
| NCT01682226 | Cord Blood With T-Cell Depleted Haplo-identical Peripheral Blood Stem Cell Transplantation for Hematological Malignancies | completed | Phase 2 | 84 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Aug 5, 2022 | clinicaltrials |
| NCT00468715 | Bicalutamide in Treating Patients With Metastatic Breast Cancer | completed | Phase 2 | 28 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Aug 3, 2022 | clinicaltrials |
| NCT02563925 | Brain Irradiation and Tremelimumab in Metastatic Breast Cancer | completed | N/A | 28 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Aug 3, 2022 | clinicaltrials |
| NCT02177175 | Carvedilol for the Prevention of Anthracycline/Anti-HER2 Therapy Associated Cardiotoxicity Among Women With HER2-Positive Breast Cancer Using Myocardial Strain Imaging for Early Risk Stratification | completed | Phase 2 | 82 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jul 12, 2022 | clinicaltrials |
| NCT03122509 | A Clinical Trial of Durvalumab and Tremelimumab, Administered With Radiation Therapy or Ablation in Patients With Colorectal Cancer | completed | Phase 2 | 25 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jul 6, 2022 | clinicaltrials |
Data updated 24 days agoSource updated unknownsource: clinicaltrials